Patent · US Active

Autoantibody biomarkers for the early detection of ovarian cancer

US11243208B2 · kind B2 · utility

1Cited by

2References

3Claims

0Family size

Assignees

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · US
The Brigham and Women's Hospital, Inc. · US

Inventors

Benjamin Katchman · Tempe, US
Karen Anderson · Guilford, US
Garrick Wallstrom · Mesa, US
Joshua LaBaer · Chandler, US
Daniel Cramer · Sharon, US

Key dates

Filing date	Jul 11, 2017
Grant date	Feb 8, 2022
Priority date	—
Expiry date	Mar 11, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.